![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LUPIN TO MARKET LUPENOX IN INDIA
LUPIN TO MARKET LUPENOX IN INDIA
India-based Lupin has entered into an agreement with ItalFarmaco, an Italian pharmaceutical company, to market the cardiovascular critical-care product Lupenox (Enoxaparin sodium injection) in the Indian market.
"Lupin has always made quality products affordable to Indian patients," said Satki Chakraborty, president for Indian-region formulations at Lupin. "Our tie-up with ItalFarmaco is yet another effort in this direction. In life critical situations, quality is of paramount importance."
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct